Poster: CLL-137 SEQUOIA: Results of a Phase 3 Randomized Study of Zanubrutinib Versus Bendamustine + Rituximab (BR) in Patients With Treatment-Naïve (TN) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Authors :: Brad S. Kahl
Krzysztof Giannopoulos
Wojciech Jurczak
Martin Šimkovič
Mazyar Shadman
Anders Österborg
Luca Laurenti
Patricia Walker
Stephen Opat
Henry Chan
Hanna Ciepluch
Richard Greil
Monica Tani
Marek Trněný
Danielle M. Brander
Ian W. Flinn
Sebastian Grosicki
Emma Verner
Jennifer R. Brown
Paolo Ghia
Jianyong Li
Tian Tian
Lei Zhou
Carol Marimpietri
Jason C. Paik
Aileen Cohen
Tadeusz Robak
Peter Hillmen
Constantine S. Tam
Source :: Clinical Lymphoma Myeloma and Leukemia. 22:S139
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Tools